Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Lamy

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|June 16, 2018
Multi-parametric quantitative MRI reveals three different white matter subtypesJack R Foucher, Olivier Mainberger, Julien Lamy, et al.
Neurology|June 14, 2013
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosisStéphane Kremer, Julien Lamy, Antoine Magnus, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 22, 2018
A double dissociation between two psychotic phenotypes: Periodic catatonia and cataphasiaJack René Foucher, Yi Fan Zhang, Mathilde Roser, et al.
Brain and Behavior|December 14, 2020
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003)Nicolas Collongues, Jens Kuhle, Charidimos Tsagkas, et al.
Brain : a Journal of Neurology|November 13, 2020
Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 miceLaetitia Degiorgis, Meltem Karatas, Marion Sourty, et al.
Neuropsychobiology|September 11, 2019
A Brain Imaging-Based Diagnostic Biomarker for Periodic Catatonia: Preliminary Evidence Using a Bayesian ApproachJack René Foucher, Clément de Billy, Ludovic Christophe Jeanjean, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 14, 2025
Individualizing rTMS in treatment-resistant depression from patient-specific perfusion abnormalities a proof-of-concept randomized trial in comparison to standard rTMS and tDCSLudovic C Dormegny-Jeanjean, Clément de Crespin de Billy, Camille Pierrat, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|June 16, 2018
Multi-parametric quantitative MRI reveals three different white matter subtypesJack R Foucher, Olivier Mainberger, Julien Lamy, et al.
Neurology|June 14, 2013
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosisStéphane Kremer, Julien Lamy, Antoine Magnus, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 22, 2018
A double dissociation between two psychotic phenotypes: Periodic catatonia and cataphasiaJack René Foucher, Yi Fan Zhang, Mathilde Roser, et al.
Brain and Behavior|December 14, 2020
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003)Nicolas Collongues, Jens Kuhle, Charidimos Tsagkas, et al.
Brain : a Journal of Neurology|November 13, 2020
Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 miceLaetitia Degiorgis, Meltem Karatas, Marion Sourty, et al.
Neuropsychobiology|September 11, 2019
A Brain Imaging-Based Diagnostic Biomarker for Periodic Catatonia: Preliminary Evidence Using a Bayesian ApproachJack René Foucher, Clément de Billy, Ludovic Christophe Jeanjean, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Plos One|June 11, 2015
Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia StagesFrederic Blanc, Sean J Colloby, Nathalie Philippi, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 14, 2025
Individualizing rTMS in treatment-resistant depression from patient-specific perfusion abnormalities a proof-of-concept randomized trial in comparison to standard rTMS and tDCSLudovic C Dormegny-Jeanjean, Clément de Crespin de Billy, Camille Pierrat, et al.
Pageof 2